Your browser doesn't support javascript.
loading
Metabolic side effects induced by olanzapine treatment are neutralized by CB1 receptor antagonist compounds co-administration in female rats.
Lazzari, P; Serra, V; Marcello, S; Pira, M; Mastinu, A.
Affiliation
  • Lazzari P; Kemotech Srl, Edificio 3, Località Piscinamanna, 09010 Pula, CA, Italy.
  • Serra V; Institute of Translational Pharmacology, UOS of Cagliari, National Research Council, Scientific and Technological Park of Sardinia - Polaris, Pula, CA, Italy.
  • Marcello S; Institute of Translational Pharmacology, UOS of Cagliari, National Research Council, Scientific and Technological Park of Sardinia - Polaris, Pula, CA, Italy.
  • Pira M; Kemotech Srl, Edificio 3, Località Piscinamanna, 09010 Pula, CA, Italy.
  • Mastinu A; Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy; Institute of Translational Pharmacology, UOS of Cagliari, National Research Council, Scientific and Technological Park of Sardinia - Polaris, Pula, CA, Italy. Electronic address: amastinu@gmail.com.
Eur Neuropsychopharmacol ; 27(7): 667-678, 2017 07.
Article in En | MEDLINE | ID: mdl-28377074
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazoles / Antipsychotic Agents / Benzodiazepines / Benzoxepins / Weight Gain / Receptor, Cannabinoid, CB1 Limits: Animals Language: En Journal: Eur Neuropsychopharmacol Year: 2017 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazoles / Antipsychotic Agents / Benzodiazepines / Benzoxepins / Weight Gain / Receptor, Cannabinoid, CB1 Limits: Animals Language: En Journal: Eur Neuropsychopharmacol Year: 2017 Document type: Article